نتایج جستجو برای: sars cov 2

تعداد نتایج: 2534203  

Journal: :The Journal of infectious diseases 2005
Tommy R Tong

Airborne transmission of the severe acute respiratory syndrome (SARS) coronavirus (CoV) has been the favored explanation for its transmission on an aircraft [1] and appeared to explain a large community outbreak of SARS in the Amoy Gardens in Hong Kong [2]. The article by Booth et al. in this issue of the Journal of Infectious Diseases [3] suggests that airborne dissemination of SARS-CoV may al...

2005
Nigel J. Temperton Paul K. Chan Graham Simmons Maria C. Zambon Richard S. Tedder Yasuhiro Takeuchi Robin A. Weiss

The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike protein (S) is a major target for neutralizing antibodies. Retroviral SARS-CoV S pseudotypes have been constructed and used to develop an in vitro microneutralization assay that is both sensitive and specific for SARS-CoV neutralizing antibodies. Neutralization titers measured by this assay are highly correlated to th...

2004
Tony Mazzulli Gabriella A. Farcas Susan M. Poutanen Barbara M. Willey Donald E. Low Jagdish Butany Sylvia L. Asa Kevin C. Kain

Efforts to contain severe acute respiratory syndrome (SARS) have been limited by the lack of a standardized, sensitive, and specific test for SARS-associated coronavirus (CoV). We used a standardized reverse transcription-polymerase chain reaction assay to detect SARS-CoV in lung samples obtained from well-characterized patients who died of SARS and from those who died of other reasons. SARS-Co...

Journal: :The Journal of infectious diseases 2005
W K Eddie Ip Kwok Hung Chan Helen K W Law Gloria H W Tso Eric K P Kong Wilfred H S Wong Yuk Fai To Raymond W H Yung Eudora Y Chow Ka Leung Au Eric Y T Chan Wilina Lim Jens C Jensenius Malcolm W Turner J S Malik Peiris Yu Lung Lau

Little is known about the innate immune response to severe acute respiratory syndrome (SARS) coronavirus (CoV) infection. Mannose-binding lectin (MBL), a key molecule in innate immunity, functions as an ante-antibody before the specific antibody response. Here, we describe a case-control study that included 569 patients with SARS and 1188 control subjects and used in vitro assays to investigate...

Journal: :Virology 2008
Yong-Kyu Chu Georgia D Ali Fuli Jia Qianjun Li David Kelvin Ronald C Couch Kevin S Harrod Julie A Hutt Cheryl Cameron Susan R Weiss Colleen B Jonsson

Phase I human clinical studies involving therapeutics for emerging and biodefense pathogens with low incidence, such as the severe acute respiratory syndrome coronavirus (SARS-CoV), requires at a minimum preclinical evaluation of efficacy in two well-characterized and robust animal models. Thus, a ferret SARS-CoV model was evaluated over a period of 58 days following extensive optimization and ...

Journal: :Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2003
Joshua S Rest David P Mindell

The sudden appearance and potential lethality of severe acute respiratory syndrome associated coronavirus (SARS-CoV) in humans has focused attention on understanding its origins. Here, we assess phylogenetic relationships for the SARS-CoV lineage as well as the history of host-species shifts for SARS-CoV and other coronaviruses. We used a Bayesian phylogenetic inference approach with sliding wi...

Journal: :Science 2005
Wendong Li Zhengli Shi Meng Yu Wuze Ren Craig Smith Jonathan H Epstein Hanzhong Wang Gary Crameri Zhihong Hu Huajun Zhang Jianhong Zhang Jennifer McEachern Hume Field Peter Daszak Bryan T Eaton Shuyi Zhang Lin-Fa Wang

Severe acute respiratory syndrome (SARS) emerged in 2002 to 2003 in southern China. The origin of its etiological agent, the SARS coronavirus (SARS-CoV), remains elusive. Here we report that species of bats are a natural host of coronaviruses closely related to those responsible for the SARS outbreak. These viruses, termed SARS-like coronaviruses (SL-CoVs), display greater genetic variation tha...

Journal: :Science 2003
Paul A Rota M Steven Oberste Stephan S Monroe W Allan Nix Ray Campagnoli Joseph P Icenogle Silvia Peñaranda Bettina Bankamp Kaija Maher Min-Hsin Chen Suxiong Tong Azaibi Tamin Luis Lowe Michael Frace Joseph L DeRisi Qi Chen David Wang Dean D Erdman Teresa C T Peret Cara Burns Thomas G Ksiazek Pierre E Rollin Anthony Sanchez Stephanie Liffick Brian Holloway Josef Limor Karen McCaustland Melissa Olsen-Rasmussen Ron Fouchier Stephan Günther Albert D M E Osterhaus Christian Drosten Mark A Pallansch Larry J Anderson William J Bellini

In March 2003, a novel coronavirus (SARS-CoV) was discovered in association with cases of severe acute respiratory syndrome (SARS). The sequence of the complete genome of SARS-CoV was determined, and the initial characterization of the viral genome is presented in this report. The genome of SARS-CoV is 29,727 nucleotides in length and has 11 open reading frames, and its genome organization is s...

Journal: :Journal of medicinal chemistry 2006
Keng-Chang Tsai Shih-Yuan Chen Po-Huang Liang I-Lin Lu Neeraj Mahindroo Hsing-Pang Hsieh Yu-Sheng Chao Lincoln Liu Donald Liu Wei Lien Thy-Hou Lin Su-Ying Wu

The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) 3C-like protease (3CL(pro) or M(pro)) is an attractive target for the development of anti-SARS drugs because of its crucial role in the viral life cycle. In this study, a compound database was screened by the structure-based virtual screening approach to identify initial hits as inhibitors of SARS-CoV 3CL(pro). Out of the 5...

2008

1. We have demonstrated for the first time that the helicase of a ribonucleic acid virus, the SARS coronavirus (SARSCoV), is a valid target for drug development. 2. Using high throughput screen and chemical synthesis, several lead compounds targeting the SARS-CoV helicase have been identified. We have shown that these compounds can inhibit SARS-CoV helicase activity and viral growth in cell cul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید